Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Naoki_Okamura
|
| gptkbp:country |
gptkb:Japan
|
| gptkbp:formedByMergerOf |
gptkb:Fujisawa_Pharmaceutical_Co.,_Ltd.
gptkb:Yamanouchi_Pharmaceutical_Co.,_Ltd. |
| gptkbp:founded |
2005
|
| gptkbp:headquarters_location |
gptkb:Tokyo
|
| https://www.w3.org/2000/01/rdf-schema#label |
Astellas Group
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:numberOfEmployees |
~15,000
|
| gptkbp:products |
prescription drugs
|
| gptkbp:servesArea |
worldwide
|
| gptkbp:stockExchange |
gptkb:Tokyo_Stock_Exchange
|
| gptkbp:stockSymbol |
4503
|
| gptkbp:website |
https://www.astellas.com/
|
| gptkbp:bfsParent |
gptkb:Astellas_Pharma_Inc.
|
| gptkbp:bfsLayer |
7
|